Billy Evans, partner of Theranos founder Elizabeth Holmes, is engaged on a new startup that seeks to ship “human well being optimization” by blood testing, according to The New York Times.
The Occasions reportedly spoke to 2 buyers pitched on the startup, referred to as Haemanthus, and in addition considered a few of Haemanthus’ advertising supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to research blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to begin with pet well being earlier than increasing to people, and it seeks to boost greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct a wide range of medical exams on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two youngsters) was sentenced to 11 years in jail for defrauding buyers, although she mentioned in a latest interview that she stays “fully dedicated to my dream of creating inexpensive healthcare options out there to everybody.”
Early Fb investor Jim Breyer informed The Occasions that his workforce was requested to speculate however declined “for lots of the similar causes we handed twice on Theranos.”
